A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases
With the Delta variant currently fueling a resurgence of new infections in the fully vaccinated population, developing an effective therapeutic drug is especially critical and urgent in fighting COVID-19. In contrast to the many efforts to repurpose existing drugs or address only one aspect of COVI...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/6c3529ada1aa4bd78d4bef494a632d38 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|